Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A diffuse large B-cell lymphoma that is categorized as N1 with high probability by the LymphGen algorithm. This is based on a combination of genetic features. Although N1 DLBCLs always have an activating mutation affecting NOTCH1, LymphGen can assign cases with this mutation to other classes, depending on the presence of other genetic features.
Biomarker and diagnostic research for N1 diffuse large B-cell lymphoma has been reported in the published literature.
No clinical trials have been registered for N1 diffuse large B-cell lymphoma.
6 publications have been identified in PubMed for N1 diffuse large B-cell lymphoma. Research spans Diagnostic / Biomarker (33%), Clinical Trial Publication (33%), and Case Report / Case Series (17%).
Mingalimov M (2026). [PMID: 42074785](https://pubmed.ncbi.nlm.nih.gov/42074785/). *J Clin Med*. [Clinical Trial Publication]
Chikagawa Y (2026). [PMID: 41143946](https://pubmed.ncbi.nlm.nih.gov/41143946/). *Int J Hematol*. [Case Report / Case Series]
Miljkovic M (2025). [PMID: 40272175](https://pubmed.ncbi.nlm.nih.gov/40272175/). *Radiol Oncol*. [Diagnostic / Biomarker]
Shen YG (2025). [PMID: 40715072](https://pubmed.ncbi.nlm.nih.gov/40715072/). *Signal Transduct Target Ther*. [Clinical Trial Publication]
Panjan M (2025). [PMID: 40507898](https://pubmed.ncbi.nlm.nih.gov/40507898/). *Int J Mol Sci*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 7:13 PM UTC
Common questions about N1 diffuse large B-cell lymphoma